Linezolid-Induced Lactic Acidosis Presenting As Acute Cholecystitis: A Case Report and Systematic Review
Authors:
Open Access
- 3 October 2024
- journal article
- case report
- Published by Springer Nature in Cureus
- Vol. 16 (10) , e70794
Abstract
Linezolid has gained increased use for the treatment of infections caused by multidrug-resistant Gram-positive bacteria in recent years. It can cause rare but potentially life-threatening lactic acidosis. Here, we presented a case report of linezolid-induced lactic acidosis (LILA), along with a systematic review of current literature.Keywords
This publication has 46 references indexed in Scilit:
- Lactic acidosis associated with standard dose linezolid in a kidney recipient with impaired renal functionThe Brazilian Journal of Infectious Diseases, 2021
- Comparative analysis of lactic acidosis induced by linezolid and vancomycin therapy using cohort and case–control studies of incidence and associated risk factorsEuropean Journal of Clinical Pharmacology, 2017
- Therapeutic drug management of linezolid: a missed opportunity for clinicians?International Journal of Antimicrobial Agents, 2016
- Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant TuberculosisEBioMedicine, 2015
- Incidence and risk factors of linezolid-induced lactic acidosisInternational Journal of Infectious Diseases, 2015
- Early lactic acidosis associated with linezolid therapy in paediatric patientsInternational Journal of Antimicrobial Agents, 2014
- Fatal lactic acidosis after prolonged linezolid exposure for treatment of multidrug-resistant tuberculosisEuropean Journal of Internal Medicine, 2009
- Early Linezolid-associated Lactic Acidosis in a Patient Treated for Tuberculous SpondylodiscitisInfection, 2008
- Lactic Acidosis after Treatment with LinezolidInfection, 2007
- Linezolid for the treatment of adults with bone and joint infectionsInternational Journal of Antimicrobial Agents, 2007